Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Natalizumab, a humanized anti-α4 integrin monoclonal antibody, is a highly effective treatment approved for MS. An association between MS and an exposure to Epstein-Barr Virus (EBV) sustained by the l...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Dis Markers
Päätekijät: Castellazzi, Massimiliano, Delbue, Serena, Elia, Francesca, Gastaldi, Matteo, Franciotta, Diego, Rizzo, Roberta, Bellini, Tiziana, Bergamaschi, Roberto, Granieri, Enrico, Fainardi, Enrico
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4460255/
https://ncbi.nlm.nih.gov/pubmed/26101453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/901312
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia